[1]李琦 彭学丰 曾炳芳 柴益民 张长青 张琥△.骨髓炎汤治疗胫骨慢性骨髓炎的临床疗效观察[J].中国中医骨伤科杂志,2020,28(01):35-37.
　LI Qi PENG Xuefeng ZENG Bingfang CHAI Yimin ZHANG Changqing ZHANG Hu.Clinical Research on the Efficacy of Gusuiyan Decoction in Treating Tibia Chronic Osteomyelitis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2020,28(01):35-37.
点击复制

骨髓炎汤治疗胫骨慢性骨髓炎的临床疗效观察()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第28卷
期数:
2020年01期
页码:
35-37
栏目:
临床研究
出版日期:
2020-01-15

文章信息/Info

Title:
Clinical Research on the Efficacy of Gusuiyan Decoction in Treating Tibia Chronic Osteomyelitis
文章编号:
1005-0205(2020)01-0035-03
作者:
李琦1 彭学丰1 曾炳芳1 柴益民1 张长青1 张琥2△
1上海市第六人民医院(上海,200233) 2上海中医药大学附属曙光医院
Author(s):
LI Qi1 PENG Xuefeng1 ZENG Bingfang1 CHAI Yimin1 ZHANG Changqing1 ZHANG Hu2△
1Shanghai Jiaotong University Affiliated Sixth People's Hospital,Shanghai 200233,China; 2Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital,Shanghai 200021,China.
关键词:
骨髓炎汤;  慢性骨髓炎;  临床疗效
Keywords:
Gusuiyan decoction;  tibia chronic osteomyelitis;  clinical efficacy
分类号:
R681.8
文献标志码:
A
摘要:
目的:评价骨髓炎汤在胫骨慢性骨髓炎治疗中的临床疗效。方法:从2016年11月至2018年8月,共收集胫骨慢性骨髓炎病例64例,按实际治疗方案分为两组(各32例)。治疗组予以骨髓炎汤治疗,同时结合对患者的舌象、脉象等综合分析,进行中医临床辨证分型,随证加减用药。对照组予以抗生素及全身支持治疗。连续治疗6个月。采用VAS评分及SF-36量表作为疗效评价标准。结果:治疗后两组VAS评分及疗效评价明显优于治疗前,差异有统计学意义(P<0.05); 治疗后两组VAS评分及治疗有效率差异无统计学意义(P>0.05); 治疗组不良反应发生率低于对照组,两者差异有统计学意义(P<0.05)。结论:骨髓炎汤可有效降低VAS评分,提高SF-36量表评分。对胫骨骨髓炎疗效良好,安全性高,值得临床推广应用。
Abstract:
Objective:To evaluate the clinical efficacy of Gusuiyan Decoction in treating tibia chronic osteomyelitis.Methods:64 patients with the tibia chronic osteomyelitis from Nov.2016 to Aug.2018 were divided into 2 groups according to actual treatment.Patients in treatment group were treated by Gusuiyan Decoction with medicine addition and reduce on accordance with comprehensive analysis of the patient's tongue image and pulse of the clinical syndrome differentiation of traditional Chinese medicine.while the control group were treated with antibiotic and general supports.All patients were evaluated by score of VAS and SF-36 after 6 months treatment.Results:The VAS scores and efficacy evaluations of the two groups were significantly better than those before treatment,and the difference was significant(P<0.05).There was no significant difference in VAS scores and treatment efficiency between the two groups after treatment(P>0.05).there was a significant difference between two groups,and the incidence of adverse reactions in the treatment group was lower than that in the control group(P<0.05).Conclusion:Gusuiyan Decoction could reduce VAS score and raise SF-36 score effectively.It has wonderful efficacy and high security on tibia osteomyelitis,which is worthy of clinical application.

参考文献/References:

[1] 刘冠峤,王磊,余斌.微小RNA与慢性骨髓炎发病机制的研究进展[J].中华实验外科杂志,2018,35(1):167-171.
[2] 黄楠,齐民,张军,等.中药骨炎方治疗胫骨慢性骨髓炎的作用机制[J].中国药师,2019,22(5):848-851.
[3] 张军,黄楠,武永刚,等.骨炎方抗家兔慢性骨髓炎的实验研究[J].中国中医骨伤科杂志,2018,26(9):14-18.
[4] LOWENBERGA D W,DE BAUNA M,SUHB G A.Newer perspectives in the treatment of chronic osteomyelitis:a preliminary outcome report[J].Injury,2019,50(1):56-61.
[5] UCKAY I,JUGUN K,GAMULIN A,et al.Chronic Osteomyelitis[J].Curr Infect Dis Rep,2012,14(5):566-575.
[6] 赵泽金,祁同宁,王立松.骨伤复原汤治疗胫骨慢性骨髓炎的疗效及对Paley、HHS评分的影响[J].辽宁中医杂志,2018,45(7):1414-1417.
[7] 张杰,李津,李云涛.清热解毒汤联合抗生素骨水泥珠链治疗慢性骨髓炎疗效及对血清TNF-α、IL-1、BMP-2水平的影响[J].现代中西医结合杂志,2018,27(34):3830-3832.
[8] 任锡禄,郝高庭,窦志芳.黄柏治疗慢性骨髓炎临床应用及药理研究进展[J].山西中医学院学报,2016,17(1):63-64.
[9] 刘念,陈伦.益气消疽方治疗慢性骨髓炎疗效观察[J].中医学报,2018,33(9):1794-1797.
[10] 蒋国鹏,黄晋,李应福,等.慢性骨髓炎辨治体会[J].中医杂志,2016,57(16):1426-1428.
[11] 孙军锁,陈时高.多次扩创联合VSD治疗慢性骨髓炎[J].实用骨科杂志,2015,21(4):380-382.
[12] 侯昌华.慢性骨髓炎患者用中医传统疗法联合VSD手段治疗的临床价值[J].中国现代药物应用,2018,12(5):56-58.
[13] 方利,刘健,朱福民,等.中药内服外敷治疗慢性骨髓炎验案一则 [J].中医杂志,2016,57(16):988-990.

备注/Memo

备注/Memo:
基金项目:国家科技支撑计划(2014BAI08B06) △通信作者 E-mail:13621898925@126.com(收稿日期:2019-08-11)
更新日期/Last Update: 2020-01-15